Thomas J. Oxley
Founder and CEO, Synchron; Instructor of Neurosurgery, Mount Sinai Health System
Tomas J. Oxley is the founding CEO of Synchron, a clinical stage neurotechnology company developing an implantable brain computer interface that restores autonomy for people with debilitating medical illnesses by reconnecting them online. A vascular and interventional neurologist and expert in brain-computer interfaces, he is a professor of medicine at the University of Melbourne (Australia) Vascular Bionics Laboratory and an instructor of neurosurgery at Mount Sinai Hospital. Oxley’s background includes working on medtech start-ups and as a stroke neurologist at Royal Melbourne Hospital. He has performed over 1,600 endovascular neurosurgical procedures and published over 100 peer-reviewed articles in journals including Nature Biotechnology, Nature Biomedical Engineering, New England Journal of Medicine and The Lancet. (Mount Sinai is a 2024 Festival Underwriter)
Previously
Brain-computer interfaces show potential to restore function to people impacted by incurable neurological conditions such as stroke, spinal cord injury, traumatic brain injury...
From revolutionary advancements aiding paralysis patients to the therapeutic treatment of PTSD, brain-computer interfaces (BCIs) possess boundless potential for merging human...